ARCHIVES

Drug Marketing; Zeneca sues Eli Lilly, Claiming Misleading Promotion of Evista

This article is from The Cancer Letter archive.

Vol. 25 No. 10 | March 12, 1999

Download PDF Visit The Full Archive

Related Articles

UICC Receives 1300 Abstracts For Congress In Oslo, Norway.

February 22, 2002

Ibrutinib Produces 68% Overall Response Rate in Phase II Trial

January 25, 2013

NCI Could Fund 840 Competing Grants Under Clinton Budget

April 16, 1993

Pancreatic Cancer Pain Reduction Concept Approved

May 23, 1986

Also Anna Barker gets new, longer title at NCI; Mark Clanton named deputy director for care, delivery.

February 13, 2004

Chi Van Dang Named Director of University Of Pennsylvania Abramson Cancer Center

July 15, 2011